GNTA has a chance to be a huge winner with ASCO coming up, which is good timing for their anticipated release of add'l Ph3 data. At .044, the risk/reward is pretty staggering.
Solid DD combined with timeliness and conviction is a recipe for profits.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.